Verastem, Inc. SEC filings VSTM
Verastem, Inc. has 1,005 filings in SEC EDGAR's recent list, going back to Mar 8, 2012. Its latest annual report, Form 10-K, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 15, 2025 | — |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| EFFECT | Filing | May 20, 2025 | — |
| CORRESP | Letter to the SEC | May 16, 2025 | — |
| UPLOAD | Letter from the SEC | May 16, 2025 | — |
| EFFECT | Filing | Mar 28, 2025 | — |
| CORRESP | Letter to the SEC | Mar 26, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 26, 2025 | — |
| SC TO-I/A | Filing | Mar 11, 2024 | — |
| SC TO-I | Filing | Feb 8, 2024 | — |
| EFFECT | Filing | Nov 20, 2023 | — |
| CORRESP | Letter to the SEC | Nov 16, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2023 | — |
| EFFECT | Filing | Apr 24, 2023 | — |
| CORRESP | Letter to the SEC | Apr 21, 2023 | — |
| CORRESP | Letter to the SEC | Apr 18, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2022 | — |
| CORRESP | Letter to the SEC | Jul 6, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2022 | — |
| EFFECT | Filing | Apr 6, 2022 | — |
| POSASR | Filing | Mar 28, 2022 | — |
| EFFECT | Filing | Apr 16, 2020 | — |
| CORRESP | Letter to the SEC | Apr 14, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2020 | — |
| D | Filing | Mar 6, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 18, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 6, 2020 | — |
| D | Filing | Jan 7, 2020 | — |
| CT ORDER | Filing | Dec 4, 2018 | — |
| 305B2 | Filing | Oct 11, 2018 | — |
| CT ORDER | Filing | Sep 18, 2018 | — |
| EFFECT | Filing | Aug 3, 2018 | — |
| CORRESP | Letter to the SEC | Aug 1, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 31, 2018 | — |
| EFFECT | Filing | Apr 24, 2017 | — |
| CORRESP | Letter to the SEC | Apr 20, 2017 | — |
| CT ORDER | Filing | Apr 18, 2017 | — |
| CORRESP | Letter to the SEC | Apr 12, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2017 | — |
| CT ORDER | Filing | Mar 20, 2015 | — |
| CT ORDER | Filing | Nov 17, 2014 | — |
| CT ORDER | Filing | Jun 30, 2014 | — |
| CT ORDER | Filing | Apr 14, 2014 | — |
| D | Filing | Mar 6, 2014 | — |
| EFFECT | Filing | Jan 8, 2014 | — |
| CT ORDER | Filing | Nov 25, 2013 | — |
| EFFECT | Filing | Feb 14, 2013 | — |
| CT ORDER | Filing | Sep 24, 2012 | — |
| D | Filing | Jul 19, 2012 | — |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VSTM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Needham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1526119
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.